News
Wegovy maker Novo Nordisk CEO to step down
Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down as the Danish drug giant faces increased competition for its weight-loss drugs and declining share price. Why it matters: Novo has faced challenges developing next-generation obesity drugs and will see its popular but pricey GLP-1s Ozempic and Wegovy subject to the next round of Medicare drug price negotiations in the U.
An American basketball player for the Indonesian league was arrested for allegedly attempting to smuggle illegal drugs to the ...
One approach that came up was to simply make experimental drugs more easily accessible. Now, the state of Montana has passed ...
More than 14 million poor Medicare beneficiaries receive the Medicare Part D Low-Income Subsidy (LIS), which further reduces ...
Cassie Ventura was back on the stand for cross-examination in the Sean "Diddy" Combs trial after accusing him of raping her ...
If found guilty of the offenses, Jarred Shaw, who played at Oklahoma State and Utah State, could receive a life sentence or ...
A drug-driver who reached speeds of 90mph has been jailed for 14 years for the death of a three-week-old baby in a crash.
13hon MSN
A Philadelphia-based drug trafficking network was disbanded after 41-pounds of fentanyl, worth more than $6 million, was ...
The findings show that memory clinics can have “the infrastructure and expertise to safely administer and care for patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback